Bacteraemia in the Very Old
Tóm tắt
Bacteraemia is a common disorder in the elderly, and its prevalence and incidence increase with age. It carries a mortality rate of 20 to 40%. The signs and symptoms of bacteraemia are often blunted or nonspecific in the elderly, and the index of suspicion should therefore be high. Comparing underlying disorders of bacteraemia between older and younger patients, the percentage of past cerebrovascular accidents, dementia and decubitus ulcer increases sharply with age, while the percentage of neutropenia is lower. Elderly patients have a predilection for anaerobic bloodstream infections, and for multiresistant bacteria, although age is not an independent risk factor for resistance. Bacterial endocarditis in the old is caused mainly by gut bacteria. Appropriate empirical antibiotic treatment reduces mortality, regardless of age. To target antibiotic treatment, the physician should consider the patient’s salient features, and the overall susceptibility of the micro-organisms in the local ecosystem. The most important supportive measure for treatment of sepsis or septic shock is fluid repletion. No non-antibiotic drug has been shown to be effective in sepsis.
Tài liệu tham khảo
Esposito AL, Gleckman RA, Cram S, et al. Community-acquired bacteremia in the elderly: analysis of one hundred consecutive episodes. J Am Geriatr Soc 1980; 28: 315–9
Meyers BR, Sherman E, Mendelson MH, et al. Bloodstream infections in the elderly. Am J Med 1989; 86: 379–84
Muder RR, Brennen C, Wagener MM, et al. Bacteremia in a long-term-care facility: a five-year prospective study of 163 consecutive episodes. Clin Infect Dis 1992; 14: 647–54
Sonnenblick M, Carmon M, Rudensky B, et al. Septicemia in the elderly: incidence, etiology, and prognostic factors. Isr J Med Sci 1990; 26: 195–9
Leibovici L, Pitlik SD, Konisberger H, et al. Bloodstream infections in patients older than eighty years. Age Ageing 1993; 22: 431–42
Gransden WR, Eykyn SJ, Phillips I. Septicaemia in the newborn and elderly. J Antimicrob Chemother 1994; 34 Suppl. A: 101–19
Gransden WR. Predictors of bacteraemia. J Hosp Infect 1991; 18 Suppl. A: 306–16
Over ninety [editorial]. Lancet 1991; 338: 858
Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115: 457–69
Natanson C, Moderator. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120: 771–83
Members of the American College of Chest Physicians/Society of Clinical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864–74
Bryan CS. Clinical implications of positive blood cultures. Clin Microbiol Rev 1989; 2: 329–53
Smith-Elekes S, Weinstein MP. Blood cultures. Infect Dis Clin North Am 1993; 7: 221–34
Windsor ACM. Bacteraemia in a geriatric unit. Gerontology 1983; 29: 125–30
Cooper GS, Shlaes DM, Salata RA. Intraabdominal infection: differences in presentation and outcome between younger patients and the elderly. Clin Infect Dis 1994; 19: 146–8
Leibovici L, Greenshtain S, Cohen O, et al. Bacteremia in febrile patients: a clinical model for diagnosis. Arch Intern Med 1991; 151: 1801–6
Mellors JW, Horwitz RI, Harvey MR, et al. A simple index to identify occult bacterial infections in adults with acute unexplained fever. Arch Intern Med 1987; 147: 666–71
Leibovici L, Cohen O, Wysenbeek AJ. Occult bacterial infection in adults with unexplained fever: validation of a diagnostic index. Arch Intern Med 1990; 150: 1270–2
Setia W, Serventi I, Lorenz P. Bacteremia in a long-term care facility. Arch Intern Med 1984; 144: 1633–5
Terpenning MS, Buggy BP, Kauffman CA. Infective endocarditis: clinical features in young and elderly patients. Am J Med 1987; 83: 626–34
Wingard E, Shlaes JH, Mortimer EA, et al. Colonization and cross-colonization of nursing home patients with trimethoprim-resistant gram-negative bacilli. Clin Infect Dis 1993; 16: 75–81
Watanakunakorn C, Patel R. Comparison of patients with enterococcal bacteremia due to strains with and without high-level resistance to gentamicin. Clin Infect Dis 1993; 17: 74–8
Leibovici L, Konisberger H, Pitlik SD, et al. A predictive index for optimizing empiric antibiotic treatment of gram-negative bacteremia. J Infect Dis 1991; 163: 193–6
Ledingham I, McArdle CS. Prospective study of the treatment of septic shock. Lancet 1978; 1: 1194–7
Rackow EC, Falk JL, Fein IA, et al. Fluid rescucitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983; 11: 839–50
Staehr Johansen K, Storgaard N, Carstensen N, et al. An international study on the occurence of multiresistant bacteria and aminoglycoside consumption patterns. Infection 1988; 16: 313–9
Sanders CC, Sanders WE. Beta-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992; 15: 824–39
Gransden WR, Phillips I. Predictive index for optimizing empiric treatment of gram-negative bacteria [letter]. J Infect Dis 1991; 164: 211–2
Extermann M, Regamey C. Empirical antibiotic treatment of sepsis in non-neutropenic patients: single agents or combination therapy? Infection 1994; 22: 5–7
Korvick JA, Bryan CS, Färber B, et al. Prospective obsevational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother 1992; 36: 2639–44
Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for pseudomonas aeruginosa bacteremia: outcome correlation in a prospective study of 200 patients. Am J Med 1989; 87: 540–6
Shusterman N, Strom BL, Murray TG, et al. Risk factors and outcome of hospital acquired acute renal failure: clinical epidemiological study. Am J Med 1987; 83: 65–71
Giamarellou H, Yialouros K, Petrikkos G, et al. Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic Gram-negative infections. J Antimicrob Chemother 1991; 27 Suppl. C: 73–9
Leibovici L, Gransden WR, Eykyn SJ, et al. Clinical index to predict bacteraemia caused by staphylococci. J Intern Med 1993; 234: 83–9
The Veterans Administration Systemic Sepsis Cooperative Study Group. The effect of high dose glucocorticoid therapy on mortality inpatients with clinical signs of systemic sepsis. N Engl J Med 1987; 317: 659–65
Bone R, Fischer C, Clemmer T, et al. Methylprednisolone in severe sepsis study group: a controlled clinical trial of high dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317: 653–8
Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet 1991; 337: 582–3
Greenman RL, Schein RMH, Martin MA, et al. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 1991; 266: 1097–102
Ziegler EJ, Fisher CJ, Sprung CL, et al. The HA-1A human monoclonal antibody against endotoxin: a randomized, double-blind placebo-controlled trial. N Engl J Med 1991; 324: 429–36
Warren HS, Danner RL, Munford RS. Anti-endotoxin monoclonal antibodies. N Engl J Med 1992; 326: 1153–7
Cross AS. Anti-endotoxin antibodies: a dead end? Ann Intern Med 1994; 121: 58–60
Aube H, Milan C, Blettery B. Risk factors for septic shock in the early management of bacteremia. Am J Med 1992; 93: 283–8
McCue JD. Gram-negative bacillary bacteremia in the elderly: incidence, ecology, etiology and mortality. J Am Geriatr Soc 1987; 35: 213–8